eyestock logo

eyestock

Markets
Catalog
Exchange: XNAS
Sector: Others
Ticker: BGLC

BG

BioNexus Gene Lab CorpNASDAQ BGLC Stock Report

Last reporting period 30 Sep, 2023

Updated 18 Sep, 2024

Last price

—

Market cap $B

0.008

Micro

Exchange

XNAS - Nasdaq

View Full Company Analysis

BioNexus Assets

0.011 B

Last period Assets ,USD

‌

What is Assets ?

Assets are the book value of the company's tangible and intangible property, as well as cash and debt rights.

See also BioNexus Gene

Company Analysis

BGLC valuation, rating, competitors, insights and company profile

Eyestock Rating

BGLC financial analysis by Eyestock methodology

Valuation

BGLC valuation using historical relative method

Statements

BGLC Income Statements, Balance Sheet and Cash Flow Statements

Dividends

BGLC dividend yield and annual dividend

What is Assets ?

Assets are the book value of the company's tangible and intangible property, as well as cash and debt rights.

What is Assets of BioNexus Gene ?

BioNexus Gene`s Assets for the period ended 2023-09-30 are 0.011 B USD

View Full Company Analysis
Watchlist

Discover

Stock AnalysisScreenerPortfolio